Chinese PLA General Hospital: Stomach Neoplasms trials
The registry lists 20 Stomach Neoplasms studies with Chinese PLA General Hospital as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 1 3Phase 2 11Phase 3 2No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Helicobacter Pylori Infection Status and Pathological Features for Predicting Gastric Cancer Biological Behavior and Prognosis: A Real-World Observational StudyRecruitingNCT07724496
- The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled TrialRecruitingNCT07212933Phase 2
- A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer.Not yet recruitingNCT06339216Phase 2
- Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric CancerRecruitingNCT04483076Phase 3
- Tumor Microenvironment in Gastric Cancer Patients Treated With Combined Immunotherapy and ChemotherapyCompletedNCT06202781
- Use of a Liquid Biopsy Signature to Detect Early-onset Gastric CancerCompletedNCT06023121
- Multimodal Prehabilitation for Resectable Gastric CancerCompletedNCT05714878Not applicable
- Neo-adjuvant Chemotherapy Evluation in Gastric Cancer Patients Based on Circulating Exosomal LncRNA-GC1Status unknownNCT05647941
- Nivolumab, S-1 Combined With Oxaliplatin Versus Nivolumab as Neoadjuvant Therapy in Advanced Gastric CancerStatus unknownNCT04782791Phase 2
- Gastric Cancer Liver Metastasis Cohort of ChinaStatus unknownNCT04574245
- Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric CancerStatus unknownNCT04367025Phase 2
- Camrelizumab, Apatinib and Nab-paclitaxel as Second-line Treatment in Advanced Gastric CancerStatus unknownNCT04182724Phase 1/2
- Comparing the Diagnostic Role of PET/MRI and of PET/CT Among Patients With Gastric CancerStatus unknownNCT03015298
- The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric CancerStatus unknownNCT03007446Phase 2
- Laparoscopic Versus Open Gastrectomy With Splenic Hilum Lymph Nodes DissectionStatus unknownNCT02980861Phase 3
- Apatinib Plus Docetaxel Versus Docetaxel as Second-line Treatment in Advanced Gastric Cancer (AHEAD-301)Status unknownNCT02596256Phase 2
- Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96Status unknownNCT02317471Phase 1/2
- T- XELOX in HER2-positive Stage III Gastric Cancer After D2 GastrectomyStatus unknownNCT02250209Phase 2
- Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor CellCompletedNCT02048540Phase 1/2
- Study of S-1 and Oxaliplatin as Neoadjuvant Chemotherapy for Locally Advanced Gastric CancerStatus unknownNCT01090505Phase 2